אימיוסיסט ישראל - עברית - Ministry of Health

אימיוסיסט

medici ltd - bcg 81 mg/vial - powder for reconstitution - bcg vaccine - for the treatment of superficial transitional cell carcinoma (tcc) of the urinary bladder, regardless of antecedent intravesical treatment superficial tcc comprises the following: carcinoma in situ (cis), papillary tumors limited to the mucosa (stage ta), papillary tumors invoiving the lamina propria but not the muscle layer of the bladder (stage t1), or any combination thereof. immucyst is indicated for treatment and prophylaxis of primary or recurrent carcinoma insitu (cis) of the urinary bladder and for prophylaxis following trans-urethral resection (tur) of primary or recurrent stage ta and/or t1 papilary tumors.

רמיקד ישראל - עברית - Ministry of Health

רמיקד

j-c health care ltd - infliximab 100 mg/vial - powder for concentrate for infusion - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

נורקורון 10 מ"ג ישראל - עברית - Ministry of Health

נורקורון 10 מ"ג

merck sharp & dohme israel ltd - vecuronium bromide 10 mg/vial - powder for solution for injection - vecuronium - adjunct to general anaesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery.

דיספורט ישראל - עברית - Ministry of Health

דיספורט

medison pharma ltd - botulinum a toxin 500 u/vial - lyophilized powder for injection - botulinum toxin - dysport is indicated for the : treatment of dynamic equinus foot deformity due to spasticity in ambulant paediatric cerebral palsy patients two years of age or older ; spasmodic torticollis in adults ; blepharospasm in adults; hemifacial spasm in adults ; treatment of spasticity of the arm post stroke; axillary hyperhydrosis ; treatment of moderate to severe glabellar lines.

דנטריום תוך ורידי 20 מג'/בקבוקון ישראל - עברית - Ministry of Health

דנטריום תוך ורידי 20 מג'/בקבוקון

neopharm ltd - dantrolene sodium 20 mg/vial - powder for solution for injection - dantrolene - for the management of fulminant hypermetabolism of skeletal muscle characteristic of malignent hyperthermia (mh) crises in patients of all ages

ארדיה 30 מ"ג ישראל - עברית - Ministry of Health

ארדיה 30 מ"ג

novartis pharma services ag - pamidronate disodium 30 mg/vial - powder for solution for infusion - pamidronic acid - treatment of: tumor induced hypercalcaemia, bone metastases and multiple myeloma. for the treatment of paget's disease of bone.

זומרה 4 מ"ג אבקה להזרקה ישראל - עברית - Ministry of Health

זומרה 4 מ"ג אבקה להזרקה

novartis pharma services ag - zoledronic acid 4 mg/vial - powder for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

זומרה ® 4 מ"ג/5 מ"ל ישראל - עברית - Ministry of Health

זומרה ® 4 מ"ג/5 מ"ל

novartis pharma services ag - zoledronic acid 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

זולדרוניק טבע 4 מ"ג/5 מ"ל ישראל - עברית - Ministry of Health

זולדרוניק טבע 4 מ"ג/5 מ"ל

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.

זולדרוניק טבע 4 מ"ג/5 מ"ל ישראל - עברית - Ministry of Health

זולדרוניק טבע 4 מ"ג/5 מ"ל

abic marketing ltd - zoledronic acid as monohydrate 4 mg/vial - concentrate for solution for infusion - zoledronic acid - treatment of hypercalcaemia of malignancy. treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors , in conjunction with standard antineoplastic therapy. prostate cancer should have progressed after treatment with at least one hormonal therapy.